{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T02:30:21Z","timestamp":1770517821270,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T00:00:00Z","timestamp":1591401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T00:00:00Z","timestamp":1591401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00296-020-04622-4","type":"journal-article","created":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T15:02:36Z","timestamp":1591455756000},"page":"1317-1325","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Treatment of refractory adult onset Still\u2019s disease with tocilizumab\u2014a single centre experience and literature review"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3074-1646","authenticated-orcid":false,"given":"Mirna","family":"Reihl Crnogaj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0692-846X","authenticated-orcid":false,"given":"Darija","family":"\u010cubeli\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7604-4040","authenticated-orcid":false,"given":"Antonija","family":"Babi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9951-6610","authenticated-orcid":false,"given":"Miroslav","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4940-0577","authenticated-orcid":false,"given":"Branimir","family":"Ani\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,6]]},"reference":[{"issue":"7","key":"4622_CR1","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","volume":"13","author":"M Gerfaud-Valentin","year":"2014","unstructured":"Gerfaud-Valentin M, Jamilloux Y, Iwaz J, S\u00e8ve P (2014) Adult-onset still\u2019s disease. Autoimmun Rev 13(7):708\u2013722","journal-title":"Autoimmun Rev"},{"issue":"1","key":"4622_CR2","first-page":"47","volume":"31","author":"C Iliou","year":"2013","unstructured":"Iliou C, Papagoras C, Tsifetaki N, Voulgari PV, Drosos AA (2013) Adult-onset Still\u2019s disease: clinical, serological and therapeutic considerations. Clin Exp Rheumatol 31(1):47\u201352","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"4622_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1080\/03009740510026616","volume":"35","author":"KJ Evensen","year":"2006","unstructured":"Evensen KJ, Nossent HC (2006) Epidemiology and outcome of adult-onset Still\u2019s disease in Northern Norway. Scand J Rheumatol 35(1):48\u201351","journal-title":"Scand J Rheumatol"},{"issue":"7","key":"4622_CR4","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1136\/ard.54.7.587","volume":"54","author":"G Magadur-Joly","year":"1995","unstructured":"Magadur-Joly G, Billaud E, Barrier JH, Pennec YL, Masson C, Renou P et al (1995) Epidemiology of adult still\u2019s disease: estimate of the incidence by a retrospective study in west France. Ann Rheum Dis 54(7):587\u2013590","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"4622_CR5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2188\/jea.7.221","volume":"7","author":"K Wakai","year":"1997","unstructured":"Wakai K, Ohta A, Tamakoshi A, Ohno Y, Kawamura T, Aoki R et al (1997) Estimated prevalence and incidence of adult Still\u2019s disease: findings by a nationwide epidemiological survey in Japan. J Epidemiol 7(4):221\u2013225","journal-title":"J Epidemiol"},{"key":"4622_CR6","doi-asserted-by":"crossref","unstructured":"Nirmala N, Brachat A, Feist E, Blank N, Specker C, Witt M, et al (2015) Gene-expression analysis of adult-onset Still\u2019s disease and systemic juvenile idiopathic arthritis is consistent with a continuum of a single disease entity. Pediatr Rheumatol Online J. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4654831\/. Accessed May 27 2018.","DOI":"10.1186\/s12969-015-0047-3"},{"issue":"39","key":"4622_CR7","doi-asserted-by":"publisher","first-page":"e1554","DOI":"10.1097\/MD.0000000000001554","volume":"94","author":"F Ortiz-Sanju\u00e1n","year":"2015","unstructured":"Ortiz-Sanju\u00e1n F, Blanco R, Riancho-Zarrabeitia L, Casta\u00f1eda S, Oliv\u00e9 A, Riveros A et al (2015) Efficacy of anakinra in refractory adult-onset still\u2019s disease: multicenter study of 41 patients and literature review. Medicine (Baltimore) 94(39):e1554","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"4622_CR8","first-page":"1058","volume":"17","author":"A Ohta","year":"1990","unstructured":"Ohta A, Yamaguchi M, Tsunematsu T, Kasukawa R, Mizushima H, Kashiwagi H et al (1990) Adult Still\u2019s disease: a multicenter survey of Japanese patients. J Rheumatol 17(8):1058\u20131063","journal-title":"J Rheumatol"},{"issue":"6","key":"4622_CR9","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/art.1780250607","volume":"25","author":"KB Elkon","year":"1982","unstructured":"Elkon KB, Hughes GR, Bywaters EG, Ryan PF, Inman RD, Bowley NB et al (1982) Adult-onset Still\u2019s disease. Twenty-year followup and further studies of patients with active disease. Arthritis Rheum 25(6):647\u2013654","journal-title":"Arthritis Rheum"},{"issue":"3","key":"4622_CR10","first-page":"592","volume":"24","author":"KH Nguyen","year":"1997","unstructured":"Nguyen KH, Weisman MH (1997) Severe sore throat as a presenting symptom of adult onset Still\u2019s disease: a case series and review of the literature. J Rheumatol 24(3):592\u2013597","journal-title":"J Rheumatol"},{"issue":"3","key":"4622_CR11","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10067-014-2487-4","volume":"33","author":"P Efthimiou","year":"2014","unstructured":"Efthimiou P, Kadavath S, Mehta B (2014) Life-threatening complications of adult-onset Still\u2019s disease. Clin Rheumatol 33(3):305\u2013314","journal-title":"Clin Rheumatol"},{"issue":"1\u20132","key":"4622_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s12026-014-8561-9","volume":"61","author":"Y Jamilloux","year":"2015","unstructured":"Jamilloux Y, Gerfaud-Valentin M, Martinon F, Belot A, Henry T, S\u00e8ve P (2015) Pathogenesis of adult-onset Still\u2019s disease: new insights from the juvenile counterpart. Immunol Res 61(1\u20132):53\u201362","journal-title":"Immunol Res"},{"issue":"11","key":"4622_CR13","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.autrev.2014.08.032","volume":"13","author":"ATJ Maria","year":"2014","unstructured":"Maria ATJ, Le Quellec A, Jorgensen C, Touitou I, Rivi\u00e8re S, Guilpain P (2014) Adult onset Still\u2019s disease (AOSD) in the era of biologic therapies: dichotomous view for cytokine and clinical expressions. Autoimmun Rev 13(11):1149\u20131159","journal-title":"Autoimmun Rev"},{"issue":"3","key":"4622_CR14","first-page":"424","volume":"19","author":"M Yamaguchi","year":"1992","unstructured":"Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H et al (1992) Preliminary criteria for classification of adult Still\u2019s disease. J Rheumatol 19(3):424\u2013430","journal-title":"J Rheumatol"},{"issue":"4","key":"4622_CR15","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3899\/jrheum.100766","volume":"38","author":"L Jiang","year":"2011","unstructured":"Jiang L, Wang Z, Dai X, Jin X (2011) Evaluation of clinical measures and different criteria for diagnosis of adult-onset Still\u2019s disease in a Chinese population. J Rheumatol 38(4):741\u2013746","journal-title":"J Rheumatol"},{"issue":"2","key":"4622_CR16","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.berh.2016.08.003","volume":"30","author":"S Casta\u00f1eda","year":"2016","unstructured":"Casta\u00f1eda S, Blanco R, Gonz\u00e1lez-Gay MA (2016) Adult-onset Still\u2019s disease: advances in the treatment. Best Pract Res Clin Rheumatol 30(2):222\u2013238","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"9","key":"4622_CR17","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1080\/1744666X.2017.1332994","volume":"13","author":"DH Yoo","year":"2017","unstructured":"Yoo DH (2017) Treatment of adult-onset still\u2019s disease: up to date. Expert Rev Clin Immunol 13(9):849\u2013866","journal-title":"Expert Rev Clin Immunol"},{"issue":"8","key":"4622_CR18","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1002\/art.27532","volume":"62","author":"S Franchini","year":"2010","unstructured":"Franchini S, Dagna L, Salvo F, Aiello P, Baldissera E, Sabbadini MG (2010) Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still\u2019s disease. Arthritis Rheum 62(8):2530\u20132535","journal-title":"Arthritis Rheum"},{"issue":"5","key":"4622_CR19","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s00296-011-1801-6","volume":"32","author":"H-A Kim","year":"2012","unstructured":"Kim H-A, Sung J-M, Suh C-H (2012) Therapeutic responses and prognosis in adult-onset Still\u2019s disease. Rheumatol Int 32(5):1291\u20131298","journal-title":"Rheumatol Int"},{"issue":"2","key":"4622_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/MD.0000000000000021","volume":"93","author":"M Gerfaud-Valentin","year":"2014","unstructured":"Gerfaud-Valentin M, Maucort-Boulch D, Hot A, Iwaz J, Ninet J, Durieu I et al (2014) Adult-onset Still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients. Medicine (Baltimore) 93(2):91\u201399","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"4622_CR21","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1080\/14712598.2019.1652591","volume":"19","author":"DH Yoo","year":"2019","unstructured":"Yoo DH (2019) Biologics for the treatment of adult-onset Still\u2019s disease. Expert Opin Biol Ther 19(11):1173\u20131190","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"4622_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13075-019-1838-6","volume":"21","author":"F Vercruysse","year":"2019","unstructured":"Vercruysse F, Barnetche T, Lazaro E, Shipley E, Lifermann F, Balageas A et al (2019) Adult-onset Still\u2019s disease biological treatment strategy may depend on the phenotypic dichotomy. Arthritis Res Ther 21(1):53","journal-title":"Arthritis Res Ther"},{"key":"4622_CR23","doi-asserted-by":"crossref","unstructured":"Giampietro C, Fautrel B (2012) Anti-Interleukin-1 Agents in Adult Onset Still\u2019s Disease. International Journal of Inflammation. https:\/\/www.hindawi.com\/journals\/iji\/2012\/317820\/. Accessed June 17 2018.","DOI":"10.1155\/2012\/317820"},{"issue":"1","key":"4622_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3109\/07853890.2014.971052","volume":"47","author":"S Kadavath","year":"2015","unstructured":"Kadavath S, Efthimiou P (2015) Adult-onset Still\u2019s disease-pathogenesis, clinical manifestations, and new treatment options. Ann Med 47(1):6\u201314","journal-title":"Ann Med"},{"issue":"1","key":"4622_CR25","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s10067-012-2105-2","volume":"32","author":"H de Boysson","year":"2013","unstructured":"de Boysson H, F\u00e9vrier J, Nicolle A, Auzary C, Geffray L (2013) Tocilizumab in the treatment of the adult-onset Still\u2019s disease: current clinical evidence. Clin Rheumatol 32(1):141\u2013147","journal-title":"Clin Rheumatol"},{"issue":"1","key":"4622_CR26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/acr.20319","volume":"63","author":"X Pu\u00e9chal","year":"2011","unstructured":"Pu\u00e9chal X, DeBandt M, Berthelot J-M, Breban M, Dubost J-J, Fain O et al (2011) Tocilizumab in refractory adult Still\u2019s disease. Arthritis Care Res 63(1):155\u2013159","journal-title":"Arthritis Care Res"},{"issue":"1","key":"4622_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10067-013-2381-5","volume":"33","author":"P Cipriani","year":"2014","unstructured":"Cipriani P, Ruscitti P, Carubbi F, Pantano I, Liakouli V, Berardicurti O et al (2014) Tocilizumab for the treatment of adult-onset Still\u2019s disease: results from a case series. Clin Rheumatol 33(1):49\u201355","journal-title":"Clin Rheumatol"},{"issue":"6","key":"4622_CR28","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1002\/art.38398","volume":"66","author":"F Ortiz-Sanju\u00e1n","year":"2014","unstructured":"Ortiz-Sanju\u00e1n F, Blanco R, Calvo-Rio V, Narvaez J, Rubio Romero E, Oliv\u00e9 A et al (2014) Efficacy of tocilizumab in conventional treatment-refractory adult-onset Still\u2019s disease: multicenter retrospective open-label study of thirty-four patients. Arthritis Rheumatol Hoboken NJ 66(6):1659\u20131665","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"issue":"2","key":"4622_CR29","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3109\/14397595.2014.899178","volume":"26","author":"E Bannai","year":"2016","unstructured":"Bannai E, Yamashita H, Kaneko S, Ueda Y, Ozaki T, Tsuchiya H et al (2016) Successful tocilizumab therapy in seven patients with refractory adult-onset Still\u2019s disease. Mod Rheumatol 26(2):297\u2013301","journal-title":"Mod Rheumatol"},{"issue":"2","key":"4622_CR30","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3899\/jrheum.130881","volume":"41","author":"O Elkayam","year":"2014","unstructured":"Elkayam O, Jiries N, Dranitzki Z, Kivity S, Lidar M, Levy O et al (2014) Tocilizumab in adult-onset Still\u2019s disease: the Israeli experience. J Rheumatol 41(2):244\u2013247","journal-title":"J Rheumatol"},{"issue":"3","key":"4622_CR31","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3109\/14397595.2014.973659","volume":"25","author":"N Nishina","year":"2015","unstructured":"Nishina N, Kaneko Y, Kameda H, Takeuchi T (2015) The effect of tocilizumab on preventing relapses in adult-onset Still\u2019s disease: a retrospective, single-center study. Mod Rheumatol 25(3):401\u2013404","journal-title":"Mod Rheumatol"},{"key":"4622_CR32","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1080\/14712598.2019.1590334","volume":"4","author":"S Casta\u00f1eda","year":"2019","unstructured":"Casta\u00f1eda S, Mart\u00ednez-Quintanilla D, Mart\u00edn-Varillas JL, Garc\u00eda-Casta\u00f1eda N, Atienza-Mateo B, Gonz\u00e1lez-Gay MA (2019) Tocilizumab for the treatment of adult-onset Still\u2019s disease. Expert Opin Biol Ther 4:273\u2013286","journal-title":"Expert Opin Biol Ther"},{"issue":"6 Suppl 102","key":"4622_CR33","first-page":"S64","volume":"34","author":"ST Song","year":"2016","unstructured":"Song ST, Kim JJ, Lee S, Kim H-A, Lee EY, Shin KC et al (2016) Efficacy of tocilizumab therapy in Korean patients with adult-onset Still\u2019s disease: a multicentre retrospective study of 22 cases. Clin Exp Rheumatol 34(6 Suppl 102):S64\u201371","journal-title":"Clin Exp Rheumatol"},{"issue":"32","key":"4622_CR34","doi-asserted-by":"publisher","first-page":"e16682","DOI":"10.1097\/MD.0000000000016682","volume":"98","author":"C-Y Wang","year":"2019","unstructured":"Wang C-Y, Guo S-H, Wang L-P, Shen H-L (2019) Refractory adult-onset Still disease treated by tocilizumab combined with methotrexate: a STROBE-compliant article. Medicine (Baltimore) 98(32):e16682","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"4622_CR35","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1080\/14397595.2017.1416924","volume":"28","author":"Y Ma","year":"2018","unstructured":"Ma Y, Wu M, Zhang X, Xia Q, Yang J, Xu S et al (2018) Efficacy and safety of tocilizumab with inhibition of interleukin-6 in adult-onset Still\u2019s disease: a meta-analysis. Mod Rheumatol 28(5):849\u2013857","journal-title":"Mod Rheumatol"},{"issue":"12","key":"4622_CR36","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1136\/annrheumdis-2018-213920","volume":"77","author":"Y Kaneko","year":"2018","unstructured":"Kaneko Y, Kameda H, Ikeda K, Ishii T, Murakami K, Takamatsu H et al (2018) Tocilizumab in patients with adult-onset still\u2019s disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial. Ann Rheum Dis 77(12):1720\u20131729","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"4622_CR37","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/rheumatology\/kez392","volume":"59","author":"H Yamada","year":"2020","unstructured":"Yamada H, Kaneko Y, Tamai H, Takeuchi T (2020) Biomarkers for disease flare in patients with adult-onset Still\u2019s disease undergoing treatment with tocilizumab. Rheumatol Oxf Engl 59(2):440\u2013442","journal-title":"Rheumatol Oxf Engl"},{"issue":"2","key":"4622_CR38","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.cyto.2012.02.006","volume":"58","author":"M Shimizu","year":"2012","unstructured":"Shimizu M, Nakagishi Y, Kasai K, Yamasaki Y, Miyoshi M, Takei S et al (2012) Tocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: the diagnostic significance of interleukin-18 and interleukin-6. Cytokine 58(2):287\u2013294","journal-title":"Cytokine"},{"issue":"3","key":"4622_CR39","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1080\/14397595.2016.1221875","volume":"27","author":"Y Tsuchida","year":"2017","unstructured":"Tsuchida Y, Sumitomo S, Shoda H, Kubo K, Fujio K, Yamamoto K (2017) Macrophage activation syndrome associated with tocilizumab treatment in adult-onset Still\u2019s disease. Mod Rheumatol 27(3):556\u2013557","journal-title":"Mod Rheumatol"},{"issue":"1","key":"4622_CR40","doi-asserted-by":"publisher","first-page":"13477","DOI":"10.1038\/s41598-017-13639-y","volume":"7","author":"T Li","year":"2017","unstructured":"Li T, Gu L, Wang X, Guo L, Shi H, Yang C et al (2017) A pilot study on tocilizumab for treating refractory adult-onset Still\u2019s disease. Sci Rep 7(1):13477","journal-title":"Sci Rep"},{"issue":"7","key":"4622_CR41","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1093\/rheumatology\/keu019","volume":"53","author":"E Savage","year":"2014","unstructured":"Savage E, Wazir T, Drake M, Cuthbert R, Wright G (2014) Fulminant myocarditis and macrophage activation syndrome secondary to adult-onset Still\u2019s disease successfully treated with tocilizumab. Rheumatol Oxf Engl 53(7):1352\u20131353","journal-title":"Rheumatol Oxf Engl"},{"issue":"1","key":"4622_CR42","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40744-018-0102-x","volume":"5","author":"A Rubbert-Roth","year":"2018","unstructured":"Rubbert-Roth A, Furst DE, Nebesky JM, Jin A, Berber E (2018) A Review of recent advances using tocilizumab in the treatment of rheumatic diseases. Rheumatol Ther 5(1):21\u201342","journal-title":"Rheumatol Ther"},{"issue":"5","key":"4622_CR43","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s00296-019-04456-9","volume":"40","author":"EH Park","year":"2020","unstructured":"Park EH, Lee EY, Shin K, Kim H-A (2020) Tocilizumab-induced anaphylaxis in patients with adult-onset Still\u2019s disease and systemic juvenile idiopathic arthritis: a case-based review. Rheumatol Int 40(5):791\u2013798","journal-title":"Rheumatol Int"},{"issue":"3","key":"4622_CR44","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/rheumatology\/kex443","volume":"57","author":"E Choy","year":"2018","unstructured":"Choy E, Caporali R, Xavier R, Fautrel B, Sanmarti R, Bao M et al (2018) Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countries. Rheumatol Oxf Engl 57(3):499\u2013507","journal-title":"Rheumatol Oxf Engl"},{"issue":"1","key":"4622_CR45","doi-asserted-by":"publisher","first-page":"22","DOI":"10.14712\/18059694.2016.51","volume":"59","author":"X Vandemergel","year":"2016","unstructured":"Vandemergel X, Vandergheynst F (2016) Efficacy of low-dose tocilizumab on relapsing adult-onset still\u2019s disease. Acta Medica (Hradec Kralove) 59(1):22\u201325","journal-title":"Acta Medica (Hradec Kralove)"},{"issue":"1","key":"4622_CR46","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1080\/03009742.2017.1314003","volume":"47","author":"E Ebstein","year":"2018","unstructured":"Ebstein E, Ea H-K (2018) Spontaneous resolution of Epstein-Barr virus-induced haemophagocytic lymphohistiocytosis in Still\u2019s disease treated by tocilizumab: a case report. Scand J Rheumatol 47(1):84\u201385","journal-title":"Scand J Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04622-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-020-04622-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04622-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T23:23:23Z","timestamp":1622935403000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-020-04622-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,6]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["4622"],"URL":"https:\/\/doi.org\/10.1007\/s00296-020-04622-4","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,6]]},"assertion":[{"value":"3 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}